RESEARCHER PROFILE (Filmed April 2024)
Associate Professor Jelena Rnjak-Kovacina
Graduate School of Biomedical Engineering
UNSW Sydney, Australia
Dr Jelena Rnjak-Kovacina is a Scientia Associate Professor and ARC Future Fellow leading a multidisciplinary group at the Graduate School of Biomedical Engineering, UNSW Sydney in Australia.
She completed her doctoral degree in Anthony Weiss’ lab at the University of Sydney and her postdoctoral training in David Kaplan’s group at Tufts University in Boston. She joined UNSW in 2014 where her research has been supported by funding from the Australian Research Council, the National Heart Foundation, the National Health & Medical Research Council, and NSW Health. She is the recipient of multiple awards, including most recently, the NSW Ministerial Award for Rising Stars in Cardiovascular Research and the Early Career Researcher of the Year (Physical Sciences) in the NSW Premier’s Prizes for Science & Engineering.
Her research interests are at the interface of biology and engineering, focusing on the development of biomimetic materials that direct cellular interactions for enhanced vascularisation and for the treatment of cardiovascular disease. In particular, she develops novel silk-based biomaterials and investigates how biomaterial properties translate to biological outcomes.
She is actively involved in the Australasian MedTech sector, including as Vice President of the Australasian Society for Biomaterials & Tissue Engineering (ASBTE), board member of the Australian Cardiovascular Alliance (ACvA) Bioengineering flagship, Fellow of the Tissue Engineering & Regenerative Medicine International Society, and through editorial roles for multiple journals. She is passionate about research training and communication.
-
Dr Kelly-Anne Masterman
RESEARCH IN NEEDLE-FREE VACCINE DELIVERY SYSTEM
@ VAXXAS, BRISBANE, QUEENSLAND, AUSTRALIA -
Hormone receptor positive breast cancer and therapy resistance
Prof Elgene Lim is a medical oncologist at St Vincent’s Hospital and Head of the Connie Johnson Breast Cancer Research Lab at the Garvan Institute. Following his PhD at the Walter & Eliza Hall Institute where he identified the aberrant cells in carriers of the BRCA1 mutant gene, a hereditary breast cancer syndrome as the culprit cells giving rise to breast cancer, he furthered his research and clinical training at the Dana-Farber Cancer Institute and Harvard Medical School. He was awarded the National Breast Cancer Foundation Practitioner Fellowship in 2014 and returned from Boston to Australia. In 2017, he was awarded the inaugural National Breast Cancer Foundation Endowed Chair, and subsequently appointed the Principal Cancer Theme Lead at UNSW.
-
Benefits of prehabilitation ahead of surgery
Dr Matthew Wallen PhD, AES, AEP is a Senior Research Fellow in Cancer Survivorship, the Deputy Lead of the Cancer Survivorship Program, and a Senior Lecturer in Exercise Science and Clinical Exercise Physiology within the College of Nursing and Health Sciences at Flinders University, in South Australia. His clinical interest focuses on improving outcomes for people requiring major surgery, specifically (1) lifestyle interventions, including exercise, nutritional, and psychological support to improve the health and wellbeing of people prior to surgery, termed ‘prehabilitation’, (2) novel physical function assessments aimed at identifying people at risk of treatment-related complications, and (3) implementation of new models of care in cancer.
